Thompson Siegel & Walmsley LLC boosted its holdings in AdvanSix Inc. (NYSE:ASIX – Free Report) by 3.7% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 286,464 shares of the company’s stock after acquiring an additional 10,232 shares during the quarter. Thompson Siegel & Walmsley LLC owned about 1.07% of AdvanSix worth $6,566,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Acadian Asset Management LLC acquired a new stake in shares of AdvanSix in the second quarter valued at about $36,000. Allspring Global Investments Holdings LLC acquired a new stake in shares of AdvanSix during the 2nd quarter valued at approximately $51,000. Inspire Advisors LLC purchased a new stake in AdvanSix during the first quarter worth $200,000. Aigen Investment Management LP purchased a new stake in shares of AdvanSix during the fourth quarter worth about $208,000. Finally, Price T Rowe Associates Inc. MD acquired a new position in shares of AdvanSix in the first quarter valued at approximately $215,000. Institutional investors and hedge funds own 86.39% of the company’s stock.
Analysts Set New Price Targets
Separately, StockNews.com raised shares of AdvanSix from a “hold” rating to a “buy” rating in a research note on Monday, August 5th.
AdvanSix Stock Up 2.4 %
Shares of NYSE:ASIX opened at $27.44 on Monday. The company has a current ratio of 1.39, a quick ratio of 0.74 and a debt-to-equity ratio of 0.31. The firm has a market cap of $732.92 million, a price-to-earnings ratio of 914.97 and a beta of 1.69. The stock’s 50-day moving average price is $27.30 and its two-hundred day moving average price is $25.95. AdvanSix Inc. has a 12-month low of $20.86 and a 12-month high of $31.97.
AdvanSix (NYSE:ASIX – Get Free Report) last released its earnings results on Friday, August 2nd. The company reported $1.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.13 by $0.35. The business had revenue of $453.48 million for the quarter, compared to analysts’ expectations of $426.80 million. AdvanSix had a net margin of 0.57% and a return on equity of 1.03%. During the same period last year, the company earned $1.18 earnings per share. On average, research analysts forecast that AdvanSix Inc. will post 1.67 EPS for the current year.
AdvanSix Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, August 27th. Stockholders of record on Tuesday, August 13th were issued a dividend of $0.16 per share. The ex-dividend date of this dividend was Tuesday, August 13th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.33%. AdvanSix’s payout ratio is 2,134.04%.
Insider Buying and Selling
In other AdvanSix news, CEO Erin N. Kane sold 1,558 shares of the business’s stock in a transaction dated Thursday, August 1st. The stock was sold at an average price of $27.89, for a total transaction of $43,452.62. Following the completion of the sale, the chief executive officer now owns 536,237 shares of the company’s stock, valued at $14,955,649.93. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In the last ninety days, insiders have sold 2,258 shares of company stock valued at $61,247. 5.60% of the stock is currently owned by company insiders.
About AdvanSix
AdvanSix Inc engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide.
See Also
- Five stocks we like better than AdvanSix
- Stock Splits, Do They Really Impact Investors?
- Symbotic’s Double-Bagger Potential as It Hits a Key Inflection
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- High Dividend Yields Make These 2 Shipping Stocks Stand Out
- What Investors Need to Know About Upcoming IPOs
- Can Celsius Stock Rebound? Analysts See 74% Upside Potential
Receive News & Ratings for AdvanSix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdvanSix and related companies with MarketBeat.com's FREE daily email newsletter.